Sfoglia per RIVISTA
IMMUNOTHERAPY
Collezione AO Ordine Mauriziano

  

Items : 7

Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab. in Immunotherapy / Immunotherapy. 2024 Aug 19:1-9. doi: 10.1080/1750743X.2024.2385881.

2024
ASL Cuneo 2
AO Ordine Mauriziano

Murianni V; Rescigno P; Banna GL; Fornarini G; Buti S; Nolè F; Catalano F; Prati G; Morelli F; Messina M; Atzori F; Tudini M; Prati V; Cavo A; Roviello G; Vignani F; Caffo O; Napoli MD; Malgeri A; Rebuzzi SE; Signori A; Damassi A; Cremante M;

Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysis. in Immunotherapy / Immunotherapy. 2022 Feb;14(2):145-153. doi: 10.2217/imt-2021-0157. Epub 2021 Nov 22.

2022
AO Ordine Mauriziano

Di Maio M; Brunelli M; Mazzaschi G; Cattrini C; Bersanelli M; Buti S;

Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group). in Immunotherapy / Immunotherapy. 2022 Feb;14(2):107-114. doi: 10.2217/imt-2021-0109. Epub 2021 Nov 17.

2022
AO Ordine Mauriziano

Pignata S; Necchi A; Buti S; Procopio G; Losanno T; Tambaro R; Naglieri E; Stellato M; Banna GL; De Giorgi U; Vignani F; Basso U; Maruzzo M; Raggi D; Farè E; Mazzaschi G; Giannatempo P; Bersanelli M;

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study. in Immunotherapy / Immunotherapy. 2020 Feb;12(2):151-159. doi: 10.2217/imt-2019-0180.

2020
AO Ordine Mauriziano

Maestri A; Massari F; Ficorella C; Schinzari G; Vaccaro V; Mollica V; Sepe P; Martelli V; Vitale MG; Torre L; Atzori F; Mucciarini C; Sorarù M; Luca E; Tomao S; Rossi E; Rossetti S; Marino PD; Tursi M; Panni S; Mazzoni F; Fornarini G; Tiseo M; Rebuzzi SE; Cortellini A; De Giorgi U; Banna GL; Buti S; Bersanelli M; et alii...

Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real life. in Immunotherapy / Immunotherapy. 2019 Jun;11(9):783-794. doi: 10.2217/imt-2019-0009. Epub 2019 May 16.

2019
AO Ordine Mauriziano

Caminati M; Arcolaci A; Guerriero M; Manzotti G; Crivellaro M; Rolla G; Fassio F; Senna G;

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. in Immunotherapy / Immunotherapy. 2018 Oct;10(14):1229-1239. doi: 10.2217/imt-2018-0080.

2018
AO Ordine Mauriziano

Bersanelli M; Giannarelli D; Castrignanò P; Fornarini G; Panni S; Mazzoni F; Tiseo M; Rossetti S; Gambale E; Rossi E; Papa A; Cortellini A; Lolli C; Ratta R; Michiara M; Milella M; De Luca E; Sorarù M; Mucciarini C; Atzori F; Banna GL; La Torre L; Vitale MG; Massari F; Rebuzzi SE; Facchini G; Schinzari G; Tomao S; Bui S; et alii...

Survivin-peptide vaccination elicits immune response after allogeneic nonmyeloablative transplantation: a safe strategy to enhance the graft versus tumor effect. in Immunotherapy / Immunotherapy. 2018 Jul;10(9):753-767. doi: 10.2217/imt-2017-0139.

2018
AO Ordine Mauriziano

Circosta P; Vitaggio K; Elia AR; Todorovic M; Sangiolo D; Carnevale-Schianca F; Vallario A; Geuna M; Aglietta M; Cignetti A;